Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Enhancing Cognitive and Postoperative Recovery After Cardiac Surgery in Older Adults (ECPON II) (ECPON II)

13 de noviembre de 2026 actualizado por: Ulrica Nilsson, Karolinska Institutet

Enhancing Cognitive Function and POstoperative Neurocognitive Recovery After Cardiac Surgery in Older Adults

Postoperative cognitive complaints are common among older adults undergoing cardiac surgery and may negatively affect recovery, daily functioning, independence, and quality of life. The ECPON II study evaluates the effectiveness of a co-designed, nurse navigator-led intervention designed to support cognitive and postoperative recovery in older adults undergoing cardiac surgery.

Fifty patients aged 65 years or older undergoing cardiac surgery will receive the intervention. Outcomes will be compared with data from 150 matched historical controls from the previous ECPON observational study (ECPON I; NCT06469515). The historical controls are not enrolled in ECPON II.

The intervention consists of four coordinated components: information and education, postoperative consultations, cognitive assessments, and peer support, coordinated and delivered by a nurse navigator. The primary outcome is patient-reported cognitive complaints. Secondary outcomes include postoperative recovery, cognitive function, delirium, frailty, depression, health-related quality of life, functional capacity, self-efficacy, caregiver burden, and cost-utility. Participants will be followed for six months after surgery.

Descripción general del estudio

Estado

Aún no reclutando

Condiciones

Intervención / Tratamiento

Descripción detallada

Postoperative neurocognitive impairment and cognitive complaints are important complications following cardiac surgery in older adults. Cognitive complaints may include difficulties with memory and concentration, fatigue, sleep disturbances, and reduced ability to manage everyday activities. These problems may influence postoperative recovery, independence, rehabilitation, and quality of life and may also affect close relatives.

ECPON II is a quasi-experimental superiority study evaluating a co-designed intervention coordinated and delivered by a nurse navigator. The intervention was developed through an experience-based co-design process involving older adults who had undergone surgery, close relatives, healthcare professionals, and scientific experts.

The intervention comprises four core components: (1) information and education regarding postoperative cognitive difficulties and strategies for managing them; (2) individualized postoperative consultations with a nurse navigator; (3) cognitive assessments before and after surgery to identify and follow cognitive difficulties and support individualized postoperative care; and (4) peer-support sessions for patients and close relatives.

Fifty patients aged 65 years or older undergoing open cardiac surgery will be prospectively enrolled and receive the intervention. Each patient will be asked to nominate a close relative who will be invited to participate in selected study activities. Close relatives will provide assessments of the patient's cognitive functioning and caregiver burden and may participate in peer-support sessions and qualitative interviews. If the patient has no close relative or the nominated person declines participation, the patient remains eligible for the study.

Outcomes in the intervention group will be compared with data from 150 matched historical controls from ECPON I (NCT06469515), an observational study conducted in the same patient population. The historical controls are used as comparator data and are not included in the ECPON II enrollment.

The primary objective is to determine whether the intervention reduces patient-reported cognitive complaints following cardiac surgery. Secondary objectives include evaluating postoperative recovery, cognitive function, self-efficacy, functional status, fatigue, depression, frailty, health-related quality of life, caregiver burden, and cost-utility.

A purposive sample of approximately 20-40 patients and their close relatives will participate in semi-structured individual interviews six months after surgery to explore experiences of the intervention, mechanisms of impact, feasibility, postoperative cognition, and recovery. In addition, all patients will be asked about any experience with postoperative delirium and, if so, to describe any long-term experiences as well as overall experience of postoperative cognition and its impact on recovery.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

50

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Copia de seguridad de contactos de estudio

  • Nombre: Lina Bergman, PhD
  • Número de teléfono: 0046 33 435 44 11
  • Correo electrónico: lina.bergman@hb.se

Ubicaciones de estudio

      • Gothenburg, Suecia
        • Sahlgrenska University Hospital, Gothenburg
        • Contacto:
          • Tor Damén, MD, PhD

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

65 años y mayores (Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Scheduled for elective or urgent open-heart surgery or minimally invasive cardiac surgery
  • Resident in the area/region for the current thoracic clinic
  • Able to read and understand Swedish

Exclusion Criteria:

  • Physical, mental, and cognitive difficulties that prevent the individual from completing the cognitive tests
  • Undergone surgery within the last 6 months

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Cuidados de apoyo
  • Asignación: N / A
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: ECPON II Nurse Navigator-led Intervention

The intervention comprises four coordinated components:

  1. Information and education: Verbal and written information about cognitive difficulties after cardiac surgery, their impact on daily life and recovery, and strategies for managing them.
  2. Postoperative consultations: An individual consultation with the nurse navigator 2-3 weeks after discharge, addressing recovery, challenges, support, and self-management. A person-centred care plan is developed, with additional consultations as needed.
  3. Cognitive assessment: Cognitive function, cognitive complaints, daily functioning, and recovery are assessed before and after surgery to guide individualized support.
  4. Peer support: Small-group sessions for patients and close relatives, facilitated by the nurse navigator, focus on shared experiences, self-management, and recovery.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Patient-reported cognitive complaints
Periodo de tiempo: Preoperatively and weekly from 3-5 days after discharge through 6 months after surgery.

Patient-reported cognitive complaints will be assessed using the Cognitive Recovery dimension of the Swedish Quality of Recovery-Cognitive (SwQoR-Cog). The dimension comprises 10 items assessing symptoms related to cognitive complaints, including fatigue, sleep difficulties, concentration difficulties, frustration, forgetfulness, difficulties reading or calculating, and reduced ability to function independently. Each symptom is rated on an 11-point numerical rating scale ranging from 0 ("none of the time") to 10 ("all of the time"), with higher scores indicating a greater symptom burden.

Preoperatively and weekly from 3-5 days after discharge through 6 months after surgery.

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Postoperative recovery
Periodo de tiempo: Preoperatively and weekly through 6 months

Evaluated with the General recovery dimension of the SwQoR-Cog, consisting of 4 items measuring symptoms related to pain, nausea, the wound, and difficulties with personal hygiene. Each item is rated on an 11-point numerical rating scale ranging from 0 ("none of the time") to 10 ("all of the time"), with higher scores indicating a greater symptom burden.

Preoperatively and weekly through 6 months
Nightmares
Periodo de tiempo: Weekly through 6 months

Patient-reported frequency/severity of nightmares rated on an 11-point numerical rating scale ranging from 0 ("none of the time") to 10 ("all of the time").

Weekly through 6 months
Cognitive function
Periodo de tiempo: Preoperatively, 1 month, 3 months and 6 months

Consortium to Establish a Registry for Alzheimer's Disease (CERAD). The CERAD measures verbal learning and memory performance. Participants are presented with a list of 10 words across three learning trials and asked to recall as many words as possible after each trail.

Preoperatively, 1 month, 3 months and 6 months
Executive functioning
Periodo de tiempo: Preoperatively, 1 month, 3 months and 6 months

Stroop Colour-Word Interference Test (SCWT) is used to assess executive functioning, selective attention, and inhibitory control. In this timed test, participants are required to identify the colour of words printed in incongruent colours as quickly and accurately as possible

Preoperatively, 1 month, 3 months and 6 months
Postoperative delirium
Periodo de tiempo: Three times daily during hospitalization

Nursing Delirium Screening Scale (Nu-DESC). The scale assesses five symptom domains associated with delirium, with higher scores reflecting greater symptom severity. A total score of 2 or above is considered indicative of delirium.

Three times daily during hospitalization
Frailty
Periodo de tiempo: Preoperatively and 6 months

Clinical Frailty Scale (CFS), a nine-point instrument that classifies individuals from very fit to terminally ill. Assessments are conducted by trained clinicians based on the individual's pre-illness functional status.

Preoperatively and 6 months
Depressive symptoms
Periodo de tiempo: Preoperatively, 1 month, 3 months and 6 months

Patient Health Questionnaire-9 (PHQ-9), nine items assessing depressive symptoms experienced during the preceding two weeks, with response options ranging from 0 ("not at all") to 3 ("nearly every day").

Preoperatively, 1 month, 3 months and 6 months
Health-related quality of life
Periodo de tiempo: Preoperatively and 6 months

RAND-36 questionnaire encompassing eight dimensions of health: physical functioning, physical role limitations, emotional role limitations, vitality, mental health, social functioning, pain, and general health. Domain scores as well as physical and mental summary scores will be calculated to provide an overall assessment of health status.

Preoperatively and 6 months
Functional capacity
Periodo de tiempo: Preoperatively, 1 month, 3 months and 6 months

World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0), 12-item version. This instrument evaluates difficulties in performing everyday activities and participating in daily life in relation to an individual's current health status. Each item is rated on a five-point scale reflecting the degree of difficulty experienced, generating a total score ranging from 0 to 48. Higher scores indicate greater disability and functional limitations

Preoperatively, 1 month, 3 months and 6 months
Self-efficacy
Periodo de tiempo: Preoperatively, 1 month, 3 months and 6 months

General Self-Efficacy Scale (GSE), 10 items assessing an individual's perceived ability to handle demanding situations and solve problems effectively. Items are rated on a four-point scale, and higher scores reflect greater self-efficacy.

Preoperatively, 1 month, 3 months and 6 months
Cognitive functioning assessed by close relatives
Periodo de tiempo: Preoperatively, 1 month, 3 months and 6 months

Cognitive Failures Questionnaire for Others (CFQ-f). The questionnaire contains eight items measuring observed cognitive difficulties in daily life, with responses provided on a five-point scale from never to always. The instrument has been translated and culturally adapted for Swedish use by our research group following back-translation procedures. The recall period was shortened from six months in the original version to one month to better reflect the postoperative recovery trajectory.

Preoperatively, 1 month, 3 months and 6 months
Caregiver burden
Periodo de tiempo: Preoperatively, 1 month, 3 months and 6 months

Zarit Burden Interview, 12-item version (ZBI-12). The instrument contains 12 items, each rated on a five-point Likert scale ranging from never to nearly always.

Preoperatively, 1 month, 3 months and 6 months
Plasma osmolality
Periodo de tiempo: Preoperatively and postoperative day 1

Osmolality will be estimated using the blood-based biomarkers sodium, glucose, and urea and calculated according to the following formula: Osmolarity (mOsm/L) = 2 × Sodium (mmol/L) + Glucose (mg/dL) / 18 + Urea (mg/dL) / 2.8.

Preoperatively and postoperative day 1
Cost-utility
Periodo de tiempo: Through 6 months

Will be assessed by calculating quality-adjusted life years (QALYs) gained using data obtained from the RAND-36.

Through 6 months

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Demographic and perioperative data
Periodo de tiempo: At baseline and perioperatively

Will be collected from the medical record.

At baseline and perioperatively

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de enero de 2027

Finalización primaria (Estimado)

1 de diciembre de 2027

Finalización del estudio (Estimado)

1 de diciembre de 2027

Fechas de registro del estudio

Enviado por primera vez

13 de noviembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

13 de noviembre de 2026

Publicado por primera vez (Actual)

19 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

19 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

13 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 2026-06328-01

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .